Edition:
United States

Rite Aid Corp (RAD.N)

RAD.N on New York Stock Exchange

1.88USD
11 Dec 2017
Change (% chg)

$-0.02 (-1.05%)
Prev Close
$1.90
Open
$1.90
Day's High
$1.93
Day's Low
$1.85
Volume
2,116,791
Avg. Vol
4,602,832
52-wk High
$8.77
52-wk Low
$1.38

Chart for

About

Rite Aid Corporation is a retail drugstore chain. The Company's segments include Retail Pharmacy and Pharmacy Services. The Company operates under The Rite Aid name. It operates approximately 4,560 stores in over 30 states across the country and in the District of Columbia. The Company's Retail Pharmacy segment consists of Rite... (more)

Overall

Beta: 1.82
Market Cap(Mil.): $2,021.52
Shares Outstanding(Mil.): 1,063.96
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 22.74 15.67
EPS (TTM): -- -- --
ROI: -- 12.06 34.62
ROE: -- 13.59 16.00

Fred's shares hit 18-year low after company pulls dividend

Discount store operator Fred's Inc said on Wednesday it had canceled its quarterly cash dividend and was exploring alternatives for some of its assets, sending its shares plunging 25 percent to their lowest in more than 18 years.

Dec 06 2017

CVS likely wants FTC antitrust review, not Justice Department, of Aetna deal

WASHINGTON It is uncertain who in the U.S. government will carry out an antitrust review of CVS Health Corp's deal to buy health insurer Aetna Inc , but the drugstore company is likely hoping the potentially more lenient Federal Trade Commission gets the nod, antitrust experts say. | Video

Dec 05 2017

Fitch Rates AmerisourceBergen's Senior Notes 'A-'; Outlook Stable

(The following statement was released by the rating agency) NEW YORK, December 05 (Fitch) Fitch Ratings has assigned an 'A-' rating to AmerisourceBergen's (ABC) sale of $750 million senior notes due 2027 and $500 million senior notes due 2047. Proceeds are expected to be used to finance the acquisition of H.D. Smith for $815 million in cash and to redeem 4.875% senior notes due Nov. 15, 2019, and for general corporate purposes. See key terms of the notes below the list of rating actions. Fitch h

Dec 05 2017

Fitch Downgrades GNC to 'B-' After Withdrawal of Refinancing Proposal; Outlook Negative

(The following statement was released by the rating agency) NEW YORK, December 05 (Fitch) Fitch Ratings has downgraded GNC Holdings, Inc.'s IDR to 'B-' from 'B' on increased refinancing risk following the announced withdrawal of its proposed refinancing offering. The Negative Outlook reflects Fitch's reduced confidence in GNC's ability to address upcoming maturities ($300 million revolver due September 2018 and $1.1 billion term loan maturity in March 2019) given the termination of its current r

Dec 05 2017

CVS likely wants FTC antitrust review, not Justice Dept, of Aetna deal

WASHINGTON, Dec 5 It is uncertain who in the U.S. government will carry out an antitrust review of CVS Health Corp's deal to buy health insurer Aetna Inc, but the drugstore company is likely hoping the potentially more lenient Federal Trade Commission gets the nod, antitrust experts say.

Dec 05 2017

BRIEF-‍Rite Aid Announces First Closings Of Asset Sale To Walgreens Boots Alliance​

* ‍RITE AID ANNOUNCES FIRST CLOSINGS OF ASSET SALE TO WALGREENS BOOTS ALLIANCE​ Source text for Eikon: Further company coverage:

Nov 27 2017

BRIEF-Rite aid announces senior management changes in category management

* Rite Aid announces senior management changes in category management

Nov 17 2017

AmerisourceBergen expects tumbling generic drug prices to settle

AmerisourceBergen Corp said it expects stubbornly low generic drug prices, which have plagued drugmakers and wholesalers, to not deteriorate further next year, and brushed off concerns about Amazon's possible entry into the industry.

Nov 02 2017

UPDATE 3-AmerisourceBergen expects tumbling generic drug prices to settle

* Shares initially rise, before reversing course (Adds details on forecast, CEO and analyst comments; updates shares)

Nov 02 2017

BRIEF-AmerisourceBergen, on conf call, says current trends indicate that generic buy side deflation rate has not worsened

* AmerisourceBergen CEO, on conf call, says an aging U.S. patient population continues to "demand" the support of pharmaceutical intervention​

Nov 02 2017

Competitors

  Price Chg
Wal-Mart Stores Inc (WMT.N) $96.93 +0.38
CVS Health Corp (CVS.N) $73.08 -0.01
AmerisourceBergen Corp. (ABC.N) $86.77 +0.07

Earnings vs. Estimates